Form 4 for SGHT Sight Sciences, Inc.
Accepted 2026-04-09 17:17:14 ET · period of report 2026-04-06 · accession 0001193125-26-149858 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-04-09 17:17 | 2026-04-06 | SGHT | Rodberg James | CFO | S - Sale | $3.55 | -7,231 | 230.9K | -3% | -$25.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-06 | S | D | 7,231 | $3.55 | 230,939 | D | — | — | (F1) Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). (F2) Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $3.43 to $3.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F3) Includes (i) 47,160 shares of Common Stock, and (ii) 183,779 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |